Evidence map›Paper›PMID 41237124›Full record

ArticlePLOS digital health2025

Continuous Glucose Monitoring under standardised conditions regarding diet, exercise and stress in Healthy Young People (CGM-HYPE study): An exploratory clinical trial.

Florian Kinny, Stephanie Läer, Emina Obarcanin

Abstract read
In one paragraph

Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Florian KinnyInstitute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.ORCID https://orcid.org/0009-0003-0408-6497
Stephanie LäerInstitute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
Emina ObarcaninInstitute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Continuous glucose monitoring (CGM) in healthy adults is becoming part of healthy lifestyle activities for preventing cardio-vascular and metabolic diseases. However, there is a lack in describing individual glucose responses to everyday situations, with appropriate metrics. The aim of this study was to provide metrics which describe individual glucose responses to lifestyle factors including diet, exercise, and stress in healthy, young adults. Ten participants wore a CGM device (FreeStyle Libre3®) for 14 consecutive days while completing nine standardized interventions (challenges) consisting of food, anaerobic and aerobic sport, and the Trier Social Stress Test (TSST) in an exploratory, clinical trial. Individual glucose responses after each challenge were assessed over four hours, using the following metrics: AUC0-4, max glucose, time to max glucose, glucose excursion, and time required for glucose levels to return to baseline (Glucose Recovery Time to Baseline (GRTB)). The study has been registered in the German clinical trial registry (Study number: DRKS00032821). Anaerobic exercise resulted in a significantly greater glucose excursion (28.7 ± 21.46 mg/dL) compared to aerobic exercise (8.8 ± 4.91 mg/dL, p = 0.0228). Food with a rich carbohydrate content caused the highest glucose increase (161.4 ± 15.59 mg/dL). TSST resulted in a significant difference in baseline-corrected glucose concentrations over time as revealed by a two-factor repeated measures ANOVA (p = 0.0113). We provide reference data of glucose response to lifestyle factors such as diet and exercise in healthy adults. Psychobiological stress revealed a substantial glucose response. Using GRTB metrics may quantify the lifestyle stimulus on the important metabolic pathway and can be utilized alongside kinetic metrics for describing individual glucose responses.

Identifiers

PMID41237124
PMCPMC12617953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.